SymBio Pharmaceuticals 대차 대조표 상태
재무 상태 기준 확인 6/6
SymBio Pharmaceuticals has a total shareholder equity of ¥5.2B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥6.1B and ¥910.0M respectively.
주요 정보
0%
부채 비율
JP¥0
부채
| 이자 보상 비율 | n/a |
| 현금 | JP¥5.13b |
| 주식 | JP¥5.16b |
| 총 부채 | JP¥910.00m |
| 총 자산 | JP¥6.07b |
최근 재무 상태 업데이트
We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely
Sep 24
Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation
Feb 09Recent updates
We're Hopeful That SymBio Pharmaceuticals (TSE:4582) Will Use Its Cash Wisely
Sep 24SymBio Pharmaceuticals Limited's (TSE:4582) 31% Share Price Surge Not Quite Adding Up
Aug 06Why Investors Shouldn't Be Surprised By SymBio Pharmaceuticals Limited's (TSE:4582) 28% Share Price Surge
Jun 11Here's Why We're Watching SymBio Pharmaceuticals' (TYO:4582) Cash Burn Situation
Feb 09If You Had Bought SymBio Pharmaceuticals' (TYO:4582) Shares Five Years Ago You Would Be Down 58%
Dec 18재무 상태 분석
단기부채: 4582's short term assets (¥6.0B) exceed its short term liabilities (¥906.0M).
장기 부채: 4582's short term assets (¥6.0B) exceed its long term liabilities (¥4.0M).
부채 대 자본 내역 및 분석
부채 수준: 4582 is debt free.
부채 감소: 4582 had no debt 5 years ago.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: 4582 has sufficient cash runway for more than 3 years based on its current free cash flow.
예측 현금 활주로: 4582 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 34.4% each year